5.71
+0(+0.00%)
Currency In USD
| Previous Close | 5.71 |
| Open | 5.71 |
| Day High | 5.94 |
| Day Low | 5.69 |
| 52-Week High | 29.3 |
| 52-Week Low | 3.76 |
| Volume | 1.51M |
| Average Volume | 1.99M |
| Market Cap | 531.28M |
| PE | -1.32 |
| EPS | -4.31 |
| Moving Average 50 Days | 5.08 |
| Moving Average 200 Days | 9.87 |
| Change | 0 |
If you invested $1000 in Myriad Genetics, Inc. (MYGN) 10 years ago, it would be worth $165.22 as of August 18, 2025 at a share price of $5.71. Whereas If you bought $1000 worth of Myriad Genetics, Inc. (MYGN) shares 5 years ago, it would be worth $402.4 as of August 18, 2025 at a share price of $5.71.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
GlobeNewswire Inc.
9 hours ago
SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective Augus
New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results
GlobeNewswire Inc.
Aug 13, 2025 12:00 PM GMT
Cancer Risk Survey shows that more than half of women at high-risk for hereditary cancer would feel "empowered" by more advanced screening like genetic testingSALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN),
Myriad Genetics Announces New $200 Million Credit Facility
GlobeNewswire Inc.
Jul 31, 2025 12:30 PM GMT
SALT LAKE CITY, July 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has closed a five-year senior secured term loan credit facility providing up